Reactive Oxygen Species (ROS) are highly reactive oxygen containing molecules involved in many important cellular function, cellular homeostasis, signaling pathways and immune response. The imbalance
ScirosBio is an acronym of “Science of ROS Biology”. Our team has in-depth scientific knowledge in ROS biology, ROS contributions to disease manifestations and ROS
SBR-001 is an “Add-on” combination therapy of two ROS modulating drugs together with standard-of-care (SoC) Temozolomide to treat Glioblastoma. Preclinical proof-of-concept was established in Orthotopic